Search Results - "EGBERTS, A"

Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT by van Geijlswijk, Ingeborg M., van der Heijden, Kristiaan B., Egberts, A. C. G., Korzilius, Hubert P. L. M., Smits, Marcel G.

“…Rationale Pharmacokinetics of melatonin in children might differ from that in adults. Objectives This study aims to establish a dose–response relationship for…”
Get full text

Busulfan target exposure attainment in children undergoing allogeneic hematopoietic cell transplantation: a single day versus a multiday therapeutic drug monitoring regimen by Bognàr, T. (Tim), Kingma, J. S. (Jurjen), Smeijsters, E. H. (Erin), van der Elst, K. C. M. (Kim), de Kanter, C. T. M. (Klaartje), Lindemans, C. A. (Caroline), Egberts, A. C. G. (Toine), Bartelink, I. H. (Imke), Lalmohamed, A. (Arief)

“…Busulfan exposure has previously been linked to clinical outcomes, hence the need for therapeutic drug monitoring (TDM). Study objective was to evaluate the…”
Get full text

The Association Between Potentially Inappropriate Prescribing and Medication-Related Hospital Admissions in Older Patients: A Nested Case Control Study by van der Stelt, C. A. K., Vermeulen Windsant-van den Tweel, A. M. A., Egberts, A. C. G., van den Bemt, P. M. L. A., Leendertse, A. J., Hermens, W. A. J. J., van Marum, R. J., Derijks, H. J.

“…Introduction Medication-related problems can cause serious adverse drug events (ADEs) that may lead to hospitalization of the patient. There are multiple…”
Get full text

The Impact of Inadequate Temperature Storage Conditions on Aggregate and Particle Formation in Drugs Containing Tumor Necrosis Factor-Alpha Inhibitors by Vlieland, N. D., Nejadnik, M. R., Gardarsdottir, H., Romeijn, S., Sediq, A. S., Bouvy, M. L., Egberts, A. C. G., van den Bemt, B. J. F., Jiskoot, W.

“…Purpose To measure aggregate and particle formation in tumor necrosis factor-alpha (TNF-α) inhibitors etanercept, adalimumab and certolizumab pegol product…”
Get full text

Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications by Abbing-Karahagopian, V., Huerta, C., Souverein, P. C., de Abajo, F., Leufkens, H. G. M., Slattery, J., Alvarez, Y., Miret, M., Gil, M., Oliva, B., Hesse, U., Requena, G., de Vries, F., Rottenkolber, M., Schmiedl, S., Reynolds, R., Schlienger, R. G., de Groot, M. C. H., Klungel, O. H., van Staa, T. P., van Dijk, L., Egberts, A. C. G., Gardarsdottir, H., De Bruin, M. L.

“…Purpose Drug utilization studies have applied different methods to various data types to describe medication use, which hampers comparisons across populations…”
Get full text

Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study by Pouwels, S, van Staa, T. P, Egberts, A. C. G, Leufkens, H. G. M, Cooper, C, de Vries, F

“…Summary This case-control study showed that current use of conventional antipsychotics, but not atypical antipsychotics, seems to be associated with an…”
Get full text

Indications for antidepressant drug prescribing in general practice in the Netherlands by Gardarsdottir, H, Heerdink, E.R, van Dijk, L, Egberts, A.C.G

“…Abstract Background The intensity of the use of antidepressants in large populations can nowadays relatively easily be estimated using databases encompassing…”
Get full text

Use of anti-depressants and the risk of fracture of the hip or femur by van den Brand, M. W. M, Samson, M. M, Pouwels, S, van Staa, T. P, Thio, B, Cooper, C, Leufkens, H. G. M, Egberts, A. C. G, Verhaar, H. J. J, de Vries, F

“…Summary Anti-depressants are used largely, but have serious side effects. We show that both selective serotonin re-uptake inhibitors (SSRIs) and tricyclic…”
Get full text

Patient and medication factors associated with preventable medication waste and possibilities for redispensing by Bekker, C. L., van den Bemt, B. J. F., Egberts, A. C. G., Bouvy, M. L., Gardarsdottir, H.

“…Background Knowledge on factors related to preventable medication waste and waste-reducing interventions, including redispensing unused medications, is needed…”
Get full text

Pharmacokinetics and Clinical Efficacy of Phenobarbital in Asphyxiated Newborns Treated with Hypothermia: A Thermopharmacological Approach by van den Broek, M. P. H., Groenendaal, F., Toet, M. C., van Straaten, H. L. M., van Hasselt, J. G. C., Huitema, A. D. R., de Vries, L. S., Egberts, A. C. G., Rademaker, C. M. A.

“…Background and Objectives Therapeutic hypothermia can influence the pharmacokinetics and pharmacodynamics of drugs, the discipline which is called…”
Get full text

The relation between risk-taking behavior and alcohol use in young adults is different for men and women by de Haan, L, Egberts, A.C.G, Heerdink, E.R

“…Highlights • Risk-taking and risk assessment increased the odds of binge drinking for both men and women. • For women the odds of non-binge drinking compared…”
Get full text

Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study by Souverein, P C, Berard, A, Van Staa, T P, Cooper, C, Egberts, A C G, Leufkens, H G M, Walker, B R

“…Objective: To assess whether use of oral glucocorticoids is associated with cardiovascular and cerebrovascular morbidity. Design and setting: Nested…”
Get full text

Risk of ischemic complications related to the intensity of triptan and ergotamine use by WAMMES-VAN DER HEIJDEN, E. A, RAHIMTOOLA, H, LEUFKENS, H. G. M, TIJSSEN, C. C, EGBERTS, A. C. G

“…To investigate whether the intensity of triptan and ergotamine use, in specific overuse, is associated with the risk of ischemic complications. We conducted a…”
Get full text

Use of antiepileptic drugs and risk of fractures : Case-control study among patients with epilepsy by SOUVEREIN, P. C, WEBB, D. J, WEIL, J. G, VAN STAA, T. P, EGBERTS, A. C. G

“…To study the association between use of antiepileptic drugs (AEDs) and risk of fractures. The authors obtained data from the General Practice Research Database…”
Get full text

Nature and frequency of prescription modifications in community pharmacies: A nationwide study in the Netherlands by Loon, W.E. (Ellen), Borgsteede, S.D. (Sander), Baas, G.W. (Gert), Kruijtbosch, M. (Martine), Buurma, H. (Henk), De Smet, P.A.G.M. Peter, Egberts, A.C.G. (Toine), Bouvy, M. (Marcel), Floor‐Schreudering, A. (Annemieke)

“…Aims To investigate the nature and frequency of prescription modifications in Dutch community pharmacies. Methods In this cross‐sectional study, Dutch…”
Get full text

Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial by Klop, C., de Vries, F., Vinks, T., Kooij, M. J., van Staa, T. P., Bijlsma, J. W. J., Egberts, A. C. G., Bouvy, M. L.

“…Summary The aim of this study was to determine whether feedback by pharmacists to prescribers of patients eligible for glucocorticoid-induced osteoporosis…”
Get full text

Quantity and economic value of unused oral anti-cancer and biological disease-modifying anti-rheumatic drugs among outpatient pharmacy patients who discontinue therapy by Bekker, C.L., Melis, E.J., Egberts, A.C.G., Bouvy, M.L., Gardarsdottir, H., van den Bemt, B.J.F.

“…Patients sometimes discontinue the use of expensive oral anti-cancer drug (OACD) or biological disease-modifying anti-rheumatic drug (bDMARD) therapies early,…”
Get full text

Development of a nomogram for the estimation of long‐term adherence to clozapine therapy using neutrophil fluorescence by Man, W. H., Pérez‐Pitarch, A., Wilting, I., Heerdink, E. R., Solinge, W. W., Egberts, A. C. G., Huitema, A. D. R.

“…Aims Previously, we have reported an association between clozapine use and elevated FL3 neutrophil fluorescence, a flow‐cytometric parameter for cell…”
Get full text

Monitoring of patients treated with lithium for bipolar disorder: an international survey by Nederlof, M., Heerdink, E. R., Egberts, A. C. G., Wilting, I., Stoker, L. J., Hoekstra, R., Kupka, R. W.

“…Background Adequate monitoring of patients using lithium is needed for optimal dosing and for early identification of patients with (potential) ADEs. The…”
Get full text

Risk Management Plans as a Tool for Proactive Pharmacovigilance: A Cohort Study of Newly Approved Drugs in Europe by Vermeer, N S, Duijnhoven, R G, Straus, S M J M, Mantel-Teeuwisse, A K, Arlett, P R, Egberts, A C G, Leufkens, H G M, De Bruin, M L

“…Risk Management Plans (RMPs) have become a cornerstone in the pharmacovigilance of new drugs in Europe. The RMP was introduced in 2005 to support a proactive…”
Get full text